BeiGene Ltd

Healthcare · EUR · F

49BA

Price

€262.73

+1.05%

Cap

€20.21B

Earnings

—

30d Trend

+0.0%

49BA

Loading chart data...

0 days · % change from startPowered by Brain47

52-week range50%

€204.80€321.32

Upper half of range — momentum is positive

BRAIN47 SIGNAL

MODERATE

Risk Level65

Quality70

Momentum47

Technical36

Fundamentals35

Raw weighted: 52×Macro 0.99 (−1%)=51

RISK LEVEL

65/100

90d Volatility

36.4%High

ATR %

3.1%High daily moves

Max Drawdown (1Y)

-31.0%Volatile

QUALITY

70/100

ROE (avg)

12.4%Good

Piotroski F-Score

8/9Strong

Debt/Equity

0.46Low leverage

Accruals

-10.3%Cash earnings

Interest Coverage

7.7xAdequate

MOMENTUM

47/100

6-1M Momentum

-3.3%Flat

1M Return

-9.8%Recent pullback

Relative Strength

-1.0% vs sectorIn-line

TECHNICAL

36/100

RSI (14)

32.4Neutral

Price vs SMA200

-17.1%Bearish trend

MACD

-2.52Bearish momentum

Bollinger Band

17%Near lower band

SMA Cross

Golden CrossGolden Cross

Trend Quality (KER)

0.424Mixed

FUNDAMENTALS

35/100

EV/EBIT

61.1Expensive

P/FCF

31.7Expensive

P/S

5.2Fair

Macro: neutral (×0.99) - Fear/Greed: 61 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months46

3-12 months28

1-5+ years ★48

Long-term compounder — quality business with growth runway

BRAIN47'S ASSESSMENT

I rate BeiGene Ltd at 51/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is quality at 70/100. I classify this as a defensive position with the strongest thesis on a long-term horizon.

DETAILED ANALYSIS

Long-term compounder — quality business with growth runway. Quality (70) and Momentum (47) are the primary strengths. I note that fundamentals is the weakest area at 35/100 — this warrants monitoring. I classify this as a defensive holding — stability characteristics and high business quality provide portfolio ballast.

defensiveScore: 51/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.